BioCentury | Jun 21, 2018
Emerging Company Profile

Getting past PTSD

...and paroxetine. Antidepressants used off-label include the SSRI fluoxetine and the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine...
BioCentury | Mar 17, 2014
Company News

Pfizer sales and marketing update

...Effexor XR venlafaxine after a pharmacist reported that one bottle contained one capsule of Tikosyn dofetilide. Effexor...
...anxiety disorder, social anxiety disorder and panic disorder with or without agoraphobia. Worldwide sales of Effexor...
BioCentury | Dec 3, 2012
Clinical News

Bupropion regulatory update

...cost-benefit assessment that the cost of each of 4 antidepressants - bupropion, duloxetine, mirtazapine and venlafaxine...
...in 2Q13 and said the assessment would be published about 8 weeks later. Mirtazapine and venlafaxine...
...Institute for Quality and Efficiency in Health Care (IQWiG), Cologne, Germany Product: Bupropion; duloxetine; mirtazapine; venlafaxine...
BioCentury | Nov 21, 2011
Product Development

Not depressed yet

...Lexapro escitalopram from Forest Laboratories Inc. and H. Lundbeck A/S ; Zoloft sertraline and Effexor XR venlafaxine...
BioCentury | Aug 8, 2011
Finance

Value vaporization

...healthcare reform and $1.5B from the loss of exclusivity for several drugs, including antidepressant Effexor venlafaxine...
BioCentury | Aug 1, 2011
Finance

Good start for Incivek

...the EU and respiratory disease drug Tussionex hydrocodone polistirex and chlorpheniramine polistirexin and neurology drug venlafaxine...
BioCentury | Jun 27, 2011
Company News

IntelliPharmaCeutics, Pfizer neurology news

...IntelliPharmaCeutics and Pfizer's Wyeth LLC subsidiary settled a 2010 suit alleging that IntelliPharmaCeutics' generic Effexor XR venlafaxine...
...granted IntelliPharmaCeutics non-exclusive rights to market a generic Effexor XR in the U.S. following FDA approval. Effexor XR...
...Effexor XR came off patent July 1, 2010. FDA accepted for review IntelliPharmaCeutics' ANDA for generic Effexor XR...
BioCentury | May 23, 2011
Clinical News

OPC-34712: Phase II data

...N.Y.) and H. Lundbeck A/S (CSE:LUN, Copenhagen, Denmark); and the generics fluoxetine, paroxetine, sertraline and venlafaxine...
BioCentury | May 17, 2011
Clinical News

Otsuka compound meets depression endpoint

...Laboratories Inc. (NYSE:FRX) and H. Lundbeck A/S (CSE:LUN); and the generics fluoxetine, paroxetine, sertraline and venlafaxine...
BioCentury | Jul 6, 2009
Clinical News

SEP-225289: Phase II data

...of a reduction in symptoms of depression vs. placebo after 8 weeks. The active control, venlafaxine...
...markets venlafaxine extended-release to treat depression, generalized and social anxiety disorders, and panic disorder as Effexor XR...
Items per page:
1 - 10 of 57